CDC report : Pfizer and Moderna vaccines are 90% effective in real-world conditions


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
90% efficiency after two doses of the Pfizer, Moderna vaccine

Under real-world conditions, the Pfizer and Moderna Covid-19 vaccines provide highly effective protection, according to a new report from the US Centers for Disease Control and Prevention.

At full vaccination, the vaccines were 90% effective at preventing infections, including infections that had no symptoms. At least 14 days after the first dose but before the second dose, they were 80% protective, according to the agency’s Morbidity and Mortality Weekly Report published Monday. The CDC said it is the first of many planned Covid-19 vaccine effectiveness studies.

The study looked at how the vaccines protected nearly 4,000 health care workers and first responders. The volunteers in the study worked in eight locations around the country and had been observed from mid-December to mid-March.

The CDC tested volunteers routinely regardless of symptoms. The CDC also monitored the volunteers through text message, e-mail and direct medical reports. The volunteers also did a nasal swab once a week.

Most of the volunteers, more than 62%, had received both doses of either a Pfizer or Moderna Covid-19 vaccine. More than 12% had received just a single dose.

Among the 2,961 people vaccinated with one or more doses and the 989 unvaccinated participants, a total of 205 had a positive PCR test for Covid-19. One hundred sixty-one infections were identified when participants were unvaccinated; eight were identified among those partially immunized and three were identified among those fully immunized — more than 14 days after their second dose of vaccine. Thirty-three identified cases were excluded because the person’s immune status was not clear.

More than 87% of Covid-19 cases had symptoms. Nearly 23% of the cases sought help from a doctor. There were two hospitalizations, but no deaths.

The results of this study are similar to what scientists saw in clinical trials for the vaccines, but studies like this are important to show how effective the vaccines are, particularly in a population that, through their work, can encounter a large number of people who have Covid-19.

The results showing the level of protection from a single dose after two weeks are similar to findings from other recent studies in the UK and Israel.

Tags : #Pfizer #Moderna #CDC #RTPCR #UK #Israel

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026